AlphaYouNG
Insider selling
Noah Goodman sold $570K of Kymera Therapeutics, Inc. (KYMR) stock
Noah Goodman, Chief Business Officer of Kymera Therapeutics, Inc. (KYMR), sold 5,000 shares of KYMR stock worth $570K, per an SEC Form 4 filed Jun 25, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade was reported on Jun 25, 2026.
KYMR has moved +1.0% since the trade date, from $116.46 to $117.67 (Sep 21, 2026 close).
- Traded
- Jun 25, 2026
- Disclosed
- Jun 25, 2026
- Filing delay
- 0 days
- Price since
- +1.0%
- Role
- Chief Business Officer
- Source
- SEC Form 4
More KYMR insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.